ContraFect Corporation (CFRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0004 (400.00%)
At close: Jul 22, 2025
ContraFect Market Cap
ContraFect has a market cap or net worth of $5.35 thousand as of August 14, 2025. Its market cap has decreased by -99.88% in one year.
Market Cap
5.35K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 15, 2014, ContraFect's market cap has decreased from 87.34M to 5.35K, a decrease of -99.99%. That is a compound annual growth rate of -59.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2025 | 5.35K | 48,554.55% |
| Dec 26, 2024 | 11.00 | -100.00% |
| Dec 29, 2023 | 321.14K | -92.34% |
| Dec 30, 2022 | 4.19M | -95.95% |
| Dec 31, 2021 | 103.45M | -26.34% |
| Dec 31, 2020 | 140.44M | 47.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |